Search Results | MSF Science Portal

Science Portal

v2.1.5655.produseast1

About MSF Science Portal

About

Frequently Asked Questions (FAQs)

v2.1.5655.produseast1

Showing 1 - 6 of 6 Items

Sort By: Relevance

Newest to oldest
Oldest to newest
Relevance

Journal Article

Commentary

How COVID-19 could benefit tuberculosis and HIV services in South Africa

Keene CM, Mohr-Holland E, Cassidy T, Scott V, Nelson AM, et al.

2020-09-01 • Lancet Respiratory Medicine

Journal Article

Letter

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients

Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V, et al.

2021-05-01 • International Journal of Tuberculosis and Lung Disease

Journal Article

Commentary

Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa

Apolisi I, Mema N, Tyeku N, Beko B, Memani B, et al.

2022-03-01 • Lancet Respiratory Medicine

Journal Article

Research

Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa

Memani B, Beko B, Dumile N, Mohr-Holland E, Daniels J, et al.

2022-06-21 • Public Health Action

Patients initiated on drug-resistant TB (DR-TB) treatment in 2019 in Khayelitsha, South Africa, with a loss to follow-up outcome were evaluated to better understand reasons for loss to f...

Journal Article

Letter

Diagnosis patterns for rifampin-resistant TB after onset of COVID-19

Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, et al.

2021-09-01 • International Journal of Tuberculosis and Lung Disease

Journal Article

Letter

A home-based care programme for rifampicin-resistant TB

Douglas-Jones B, Mohr-Holland E, Mema N, Mathee S, Mathews G, et al.

2021-07-01 • International Journal of Tuberculosis and Lung Disease